Patent · US Active

Anti-IL-36R antibody formulations

US11730812B2 · kind B2 · utility

1Cited by

7References

40Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Sandra Nicole DENKINGER · Biberach an der Riß, DE
Anna Maria STEINER · Eberhardzell, DE
Derrick S. Katayama · Timnath, US
Rajni Prasad MEHRA · Pleasanton, US
Ingo Presser · Biberach, DE
Ravija SINGH · Fremont, US
Sara Kay WRIGHT · Castro Valley, US

Key dates

Filing date	Mar 5, 2020
Grant date	Aug 22, 2023
Priority date	—
Expiry date	Mar 5, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to anti-interleukin-36 receptor (anti-IL-36R1) antibody formulations for administration to a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.